journal
MENU ▼
Read by QxMD icon Read
search

Pharmaceutical Patent Analyst

journal
https://www.readbyqxmd.com/read/30101657/what-is-holding-up-the-unified-patent-court
#1
Liz Cohen, Alan Johnson
A form of unified patent protection has been available in Europe since the 1970s, but enforcement remains purely a national matter. After many years' negotiation, an agreement was signed in February 2013 to create a pan-European court (the UPC), potentially affecting global litigation strategies. A constitutional complaint brought in Germany in 2017 has delayed the project and potentially presents an existential challenge, but more likely the issue is how much further delay it will cause. It remains entirely possible the UPC will start in Q1 2019 (before Brexit)...
September 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/30066608/three-years-on-from-teva-where-are-we-now
#2
Kenneth R Adamo, Eugene Goryunov, Ryan M Hubbard, Sarah M Craig
No abstract text is available yet for this article.
September 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/30066605/gallium-68-methodology-and-novel-radiotracers-for-positron-emission-tomography-2012-2017
#3
Sean S Tanzey, Stephen Thompson, Peter Jh Scott, Allen F Brooks
Commercial 68 Ge/68 Ga generators provide a means to produce positron emission tomography agents on site without use of a cyclotron. This development has led to a rapid growth of academic literature and patents ongallium-68 (68 Ga). As 68 Ga positron emission tomography agents usually involve a targeting moiety attached to a metal chelator, the development lends itself to the investigation of theragnostic applications; the 68 Ga-based diagnostic is utilized to determine if the biological target is present and, if so, a therapeutic isotope (e...
September 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/30066597/patent-highlights-april-may-2018
#4
Hermann Am Mucke
No abstract text is available yet for this article.
September 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/30066594/advances-in-patented-cb1-receptor-antagonists-for-obesity
#5
Mange Ram Yadav, Prashant R Murumkar
No abstract text is available yet for this article.
September 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29882730/novel-patented-markers-of-immune-checkpoint-inhibitor-efficacy
#6
Matthieu Collin
No abstract text is available yet for this article.
July 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29882729/patent-highlights-february-march-2018
#7
Hermann Am Mucke
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research development.
July 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29882724/celastrol-as-a-pentacyclic-triterpenoid-with-chemopreventive-properties
#8
Priya Yadav, Vishal Jaswal, Ajay Sharma, Dharambir Kashyap, Hardeep S Tuli, Vivek K Garg, Shonkor K Das, R Srinivas
Celastrol is a highly investigated anticancer moiety. It is a pentacyclic triterpenoid, isolated several decades ago with promising role in chemoprevention. Celastrol has been found to target multiple proinflammatory, angiogenic and metastatic proteins. Inhibition of these targets results in significant reduction of cancer growth, survival and metastasis. This review summarizes the varied molecular targets of celastrol along with insight into the various recently published clinical, preclinical and industrial patents (2011-2017)...
July 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29882720/spc-update-advocate-general-opines-on-the-meaning-of-protected-by
#9
Saufung Ma, Belinda Lavin
No abstract text is available yet for this article.
July 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29882718/disruption-and-development-the-evolving-crispr-patent-and-technology-landscape
#10
Daniel Lim
No abstract text is available yet for this article.
July 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29882713/arrow-declarations-here-to-stay-or-a-flash-in-the-pan
#11
Dominic Adair
No abstract text is available yet for this article.
July 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29676653/tissue-targeted-nanocapsids-for-oral-insulin-delivery-via-drink
#12
Chun C Chen, Mo A Baikoghli, R Holland Cheng
For the past eight decades, subcutaneous injection has been the main route used for supplementing the suboptimal insulin secretion for administering insulin as a treatment for diabetes mellitus. Although this method is effective, subcutaneous injections are painful, inconvenient and carry a high risk of infections leading to poor patient compliance. The insulin-encapsulated hepatitis E virus nanoparticle, composed of the noninfectious hepatitis E viral capsid, is expected to deliver insulin from the GI tract to the liver after ingestion...
May 1, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29676211/patent-highlights-from-december-2017-to-january-2018
#13
Hermann Am Mucke
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.
May 1, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29629839/advances-in-patented-interpenetrating-polymeric-networks-for-biomedical-applications
#14
Pradeep Kumar, Yahya E Choonara, Lisa C du Toit, Viness Pillay
No abstract text is available yet for this article.
May 1, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29629820/recent-gene-delivery-patents-for-treatment-of-atherosclerosis
#15
Ambikanandan Misra
No abstract text is available yet for this article.
May 1, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29629817/trends-in-patented-chromones-for-skin-diseases
#16
Maria J Matos
No abstract text is available yet for this article.
May 1, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29553304/patenting-of-polymorphs
#17
Runjhun Tandon, Nitin Tandon, Rajesh Kumar Thapar
No abstract text is available yet for this article.
March 19, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29553297/experimental-data-required-to-support-second-medical-use-claims
#18
Jacqueline Satchell, Janelle Borham
The timing of filing a new patent application always requires a judgment call to be made between securing the earliest filing date and waiting to collect enough data to ensure the claims are fully supported and enabled across their scope. In addition, it is important to ensure that the application is drafted in such a way that it is suitable for filing in various jurisdictions. The case law we have considered for the sufficiency/enablement of second medical use claims in Europe, the USA and Australia makes it clear that experimental results should be included in the application at filing, and that the results must demonstrate that the claimed pharmaceutical product could be reasonably expected to treat the claimed indication...
March 19, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29553290/brexit-and-uk-market-exclusivities
#19
Peter Norman
No abstract text is available yet for this article.
March 19, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29417888/prior-art-takes-new-shapes-relying-on-non-traditional-prior-art-to-invalidate-a-patent
#20
REVIEW
MaryAnne Armstrong
No abstract text is available yet for this article.
March 1, 2018: Pharmaceutical Patent Analyst
journal
journal
47821
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"